Related Experiment Video
Updated: Jul 20, 2026
08:08
Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
Published on: June 18, 2013
[Pharmacokinetics in newborns and infants]
1Klinik für Anästhesie und operative Intensivmedizin, Städtische Kliniken Bielefeld gem.GmbH. roeper@sk-bielefeld.de
Summary
Anesthetic drug pharmacokinetics and pharmacodynamics change significantly in neonates and infants due to rapid physiological development. Individualized dosing is crucial for safe and effective anesthesia in this diverse pediatric population.
Area of Science:
- Anesthesiology
- Pediatric Pharmacology
- Neonatal Physiology
Context:
- Neonates and infants exhibit rapid physiological maturation impacting drug handling.
- Organ system development, particularly hepatic and renal functions, is critical for anesthetic pharmacokinetics.
- Body composition and plasma protein changes alter drug distribution and free fraction.
Purpose:
- To review the physiological changes affecting anesthetic drug pharmacokinetics in neonates and infants.
- To highlight the pharmacokinetic and pharmacodynamic variations in pediatric anesthesia.
- To emphasize the need for individualized anesthetic drug dosing in this population.
Summary:
- Immature hepatic enzyme systems lead to reduced metabolism of certain anesthetic agents.
- Increased enzymatic capacity and clearance occur within the first year of life, sometimes exceeding adult levels until puberty.
- Altered drug sensitivity, such as to volatile anesthetics and neuromuscular blockers, necessitates careful titration.
Impact:
- Understanding these pharmacokinetic and pharmacodynamic shifts is essential for optimizing anesthetic management.
- Individualized dosing strategies are required to prevent toxicity and ensure therapeutic efficacy.
- This knowledge supports safer and more effective anesthesia practices in neonates and infants.
Related Concept Videos
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...